GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) » Definitions » Total Inventories

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Total Inventories : ₦2,182 Mil (As of Jun. 2023)


View and export this data going back to 2001. Start your Free Trial

What is GlaxoSmithKline Consumer Nigeria Total Inventories?

GlaxoSmithKline Consumer Nigeria's total inventories for the quarter that ended in Jun. 2023 was ₦2,182 Mil. GlaxoSmithKline Consumer Nigeria's average total inventories from the quarter that ended in Dec. 2022 to the quarter that ended in Jun. 2023 was ₦2,961 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. GlaxoSmithKline Consumer Nigeria's Net-Net Working Capital per share for the quarter that ended in Jun. 2023 was ₦2.92.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. GlaxoSmithKline Consumer Nigeria's Days Inventory for the three months ended in Jun. 2023 was 111.76.

Inventory Turnover measures how fast the company turns over its inventory within a year. GlaxoSmithKline Consumer Nigeria's Inventory Turnover for the quarter that ended in Jun. 2023 was 0.82.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. GlaxoSmithKline Consumer Nigeria's Inventory-to-Revenue for the quarter that ended in Jun. 2023 was 0.79.


GlaxoSmithKline Consumer Nigeria Total Inventories Historical Data

The historical data trend for GlaxoSmithKline Consumer Nigeria's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Consumer Nigeria Total Inventories Chart

GlaxoSmithKline Consumer Nigeria Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Inventories
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,938.71 5,524.92 3,282.44 6,045.40 3,739.54

GlaxoSmithKline Consumer Nigeria Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,260.41 5,205.62 3,848.20 3,739.54 2,182.24

GlaxoSmithKline Consumer Nigeria Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


GlaxoSmithKline Consumer Nigeria  (NSA:GLAXOSMITH) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

GlaxoSmithKline Consumer Nigeria's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2023 is

Net-Net Working Capital Per Share (Q: Jun. 2023 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(21203.332+0.75 * 2997.004+0.5 * 2182.243-21053.574
-0-0)/1195.88
=2.92

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

GlaxoSmithKline Consumer Nigeria's Days Inventory for the three months ended in Jun. 2023 is calculated as:

Days Inventory=Average Total Inventories (Q: Jun. 2023 )/Cost of Goods Sold (Q: Jun. 2023 )*Days in Period
=2960.8915/2417.612*365 / 4
=111.76

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

GlaxoSmithKline Consumer Nigeria's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Jun. 2023 ) / Average Total Inventories (Q: Jun. 2023 )
=2417.612 / 2960.8915
=0.82

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

GlaxoSmithKline Consumer Nigeria's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Jun. 2023 ) / Revenue (Q: Jun. 2023 )
=2960.8915 / 3731.801
=0.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


GlaxoSmithKline Consumer Nigeria Total Inventories Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Consumer Nigeria's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Industrial Avenue, Ilupeju, P.M.B. 21218, Ikeja, GSK House, Lagos, NGA
GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Headlines

No Headlines